Drugs in the Pipeline
Mixed Results for Baricitinib in Trial of Hospitalized COVID-19 Patients
Findings showed that the trial did not meet statistical significance on the primary endpoint.
Your search for supplemental oxygen returned 2 results
Drugs in the Pipeline
Phase 2a study of FG-4592 for the treatment of anemia associated with chronic kidney disease (CKD)
FibroGen announced data from its Phase 2a study of FG-4592 (oral anemia therapy) in patients with stage 3-4 chronic kidney disease (CKD) and anemia.
